NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“ Field Trip“), a leader in the development and delivery of psychedelic therapies, is pleased to announce it has entered into an agreement with Bloom Burton Securities Inc. (“Bloom Burton” or the…


Previous articlePsychedelic Spotlight: Entheon Biomedical
Next articlePTSF48 – Decriminalization, Embracing the Mystical, and a Plea for More Ethical Exploration